Reaction Details | |||
---|---|---|---|
Report a problem with these data | |||
Target | Muscarinic acetylcholine receptor M2 | ||
Ligand | BDBM50522830 | ||
Substrate/Competitor | n/a | ||
Meas. Tech. | ChEMBL_1888527 (CHEMBL4390204) | ||
Ki | 12±n/a nM | ||
Citation | Yamashita, Y; Tanaka, KI; Yamakawa, N; Asano, T; Kanda, Y; Takafuji, A; Kawahara, M; Takenaga, M; Fukunishi, Y; Mizushima, T Chemical modification-mediated optimisation of bronchodilatory activity of mepenzolate, a muscarinic receptor antagonist with anti-inflammatory activity. Bioorg Med Chem27:3339-3346 (2019) [PubMed] Article | ||
More Info.: | Get all data from this article, Assay Method | ||
Muscarinic acetylcholine receptor M2 | |||
Name: | Muscarinic acetylcholine receptor M2 | ||
Synonyms: | ACM2_HUMAN | CHRM2 | Cholinergic, muscarinic M2 | Muscarinic acetylcholine receptor M2 and M4 | Muscarinic acetylcholine receptor M2 and M5 | RecName: Full=Muscarinic acetylcholine receptor M2 | ||
Type: | GPCR | ||
Mol. Mass.: | 51730.61 | ||
Organism: | Homo sapiens (Human) | ||
Description: | P08172 | ||
Residue: | 466 | ||
Sequence: |
| ||
BDBM50522830 | |||
n/a | |||
Name | BDBM50522830 | ||
Synonyms: | CHEMBL4474694 | ||
Type | Small organic molecule | ||
Emp. Form. | C31H36BrNO3 | ||
Mol. Mass. | 550.526 | ||
SMILES | [Br-].OC(C(=O)OC1C[N+]2(CCCCc3ccccc3)CCC1CC2)(c1ccccc1)c1ccccc1 |(12.18,-50.24,;3.1,-51.96,;4.44,-52.74,;5.77,-53.5,;5.78,-55.04,;7.1,-52.73,;8.44,-53.5,;9.77,-52.72,;11.09,-53.5,;12.43,-52.73,;13.76,-53.5,;15.09,-52.73,;16.43,-53.51,;17.76,-52.74,;19.09,-53.52,;20.42,-52.75,;20.42,-51.21,;19.08,-50.44,;17.75,-51.21,;11.1,-55.04,;9.77,-55.8,;8.44,-55.04,;9.93,-54.83,;9.58,-53.78,;4.43,-51.2,;5.76,-50.43,;5.76,-48.89,;4.42,-48.12,;3.09,-48.9,;3.1,-50.44,;3.1,-53.51,;1.77,-52.74,;.44,-53.51,;.44,-55.05,;1.79,-55.82,;3.11,-55.04,)| | ||
Structure |